Fact check
“After that, physicians review a sample of at least 10% of prescriptions.”
Reasoning
The claim is directly supported by two independent articles describing Nolla Health's AI prescription workflow. Each article mentions that physicians review a sample of at least 10% of prescriptions (monthly) as part of the safety protocol.
On confidence: Both primary sources explicitly state that physicians review a sample of at least 10% of prescriptions each month.
Important context
The review applies to Nolla Health's AI‑generated acne prescription pilot in Utah and is part of a broader safety process that also includes reviewing any case with escalation or side effects.
Evidence
Supporting (2)
- Tier 1 — Primary sourceNolla Health Launches the Nation's First AI-Powered Prescriptions
directly, and a physician reviews every case after the fact, at least weekly. Stage three: physicians review a sample of at least 10% of prescriptions every month, plus every case involving an escalation or a side effect. Stage one runs…
- Tier 1 — Primary sourceThis startup is issuing AI-generated acne prescriptions | The Verge
that, physicians review a sample of at least 10% of prescriptions every month, plus every case involving an escalation or side effect,” Nolla Health says . Several other healthcare companies are experimenting with AI-generated…
Limitations
The evidence is limited to Nolla Health's specific program; the claim may not generalize to all AI prescription systems or other healthcare settings. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 5, 2026, 3:42 PM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
This startup is issuing AI-generated acne prescriptionsThe Verge · Emma Roth